STRM CFO Reports Merger Cash-Out; Restricted Awards Cashed at $5.34

Rhea-AI Filing Summary

Bryant J. Reeves, III, Chief Financial Officer of Streamline Health Solutions, Inc. (STRM), reported a disposition of common stock tied to the company's merger that became effective on 08/12/2025. Under the Merger Agreement, each share of common stock outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash per share.

The filing specifically notes that 9,499 restricted shares were included and were converted into cash equal to the number of shares multiplied by the Merger Consideration, less applicable withholding taxes. The Form 4 shows a reported amount of 13,515 shares listed in the beneficial ownership column following the reported transactions. The disclosure documents an insider cash settlement and the company's transition to being a wholly owned subsidiary of the acquirer.

Positive

• Fixed cash consideration of $5.34 per share provides a clear, determinable cash exit for holders
• Restricted awards converted to cash ensures holders of unvested awards receive settlement value
• Merger achieved effective date, completing the transaction mechanics described in the Merger Agreement

Negative

• Issuer became a wholly owned subsidiary, eliminating public equity exposure for shareholders
• Cash proceeds on restricted awards are reduced by applicable withholding taxes
• Form 4 reports insider disposals, which reduce the reporting person's public equity position

Insights

Financial Analyst

TL;DR: Insider reported cash conversion at $5.34 per share as the company was merged and became a wholly owned subsidiary; this is material for shareholders.

The Form 4 confirms consummation of a merger structure in which outstanding common shares were cancelled and converted into a fixed cash payment of $5.34 per share, a definitive consideration that determines cash proceeds to former public shareholders. The filing also identifies 9,499 restricted shares that were cashed out subject to withholding. For investors, this is a conclusive liquidity event that settles equity claims in cash and removes ongoing public equity exposure.

M&A / Corporate Governance Specialist

TL;DR: The disclosure documents standard merger mechanics: share cancellation, cash-out of restricted awards, and conversion of the issuer into a wholly owned subsidiary.

The explanatory notes state that at the Effective Time every outstanding common share was cancelled and converted into the right to receive $5.34 in cash and that restricted stock awards were similarly converted into cash (net of withholding). The filing therefore documents final equity treatment under the Merger Agreement and confirms the issuer now survives as a wholly owned subsidiary of the parent—an outcome that changes governance, reporting status, and public ownership structure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reeves Bryant J III

(Last) (First) (Middle)

2400 OLD MILTON PARKWAY

BOX 1353

(Street)

ALPHARETTA GA 30009

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STREAMLINE HEALTH SOLUTIONS INC. [ STRM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value	08/12/2025		D(1)		13,515(2)	D	(1)(2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2025, by and among the Issuer, Mist Holding Co. ("Parent"), and MD BE Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer, effective as of August 12, 2025, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.01 per share, of the Company ("Common Stock") issued and outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash, without interest (the "Merger Consideration").

2. Includes 9,499 shares of restricted stock. Pursuant to the terms of the Merger Agreement, at the Effective Time, each restricted stock award corresponding to shares of Common Stock that was outstanding and unvested as of immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of Common Stock corresponding to such award of restricted stock immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration, less applicable withholding taxes.

	/s/ Bryant J. Reeves, III	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the Form 4 for Streamline Health (STRM) report?

The Form 4 reports dispositions tied to a merger in which outstanding common stock was canceled and converted into cash under the Merger Agreement.

What was the cash consideration per share in the Streamline Health merger?

The Merger Consideration was $5.34 per share in cash.

How many restricted shares were included in the reported conversion?

The filing states it includes 9,499 restricted shares, which were converted into cash equal to the share count times the Merger Consideration, less withholding taxes.

Who filed the Form 4 and what is their role at STRM?

The Form 4 was filed by Bryant J. Reeves, III, who is identified as the company's Chief Financial Officer.

What beneficial ownership amount is shown following the reported transactions?

The Form 4 shows 13,515 shares in the column for amount of securities beneficially owned following the reported transaction(s).